JP2016104790A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016104790A5 JP2016104790A5 JP2016006778A JP2016006778A JP2016104790A5 JP 2016104790 A5 JP2016104790 A5 JP 2016104790A5 JP 2016006778 A JP2016006778 A JP 2016006778A JP 2016006778 A JP2016006778 A JP 2016006778A JP 2016104790 A5 JP2016104790 A5 JP 2016104790A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- vector
- tissue
- dna encoding
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008119324 | 2008-04-30 | ||
| JP2008119324 | 2008-04-30 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014019961A Division JP5960735B2 (ja) | 2008-04-30 | 2014-02-05 | 損傷組織の機能的再生促進医薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016104790A JP2016104790A (ja) | 2016-06-09 |
| JP2016104790A5 true JP2016104790A5 (enExample) | 2016-07-21 |
Family
ID=41255155
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510169A Expired - Fee Related JP5814549B2 (ja) | 2008-04-30 | 2009-04-30 | 損傷組織の機能的再生促進医薬 |
| JP2014019961A Active JP5960735B2 (ja) | 2008-04-30 | 2014-02-05 | 損傷組織の機能的再生促進医薬 |
| JP2016006778A Ceased JP2016104790A (ja) | 2008-04-30 | 2016-01-18 | 損傷組織の機能的再生促進医薬 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510169A Expired - Fee Related JP5814549B2 (ja) | 2008-04-30 | 2009-04-30 | 損傷組織の機能的再生促進医薬 |
| JP2014019961A Active JP5960735B2 (ja) | 2008-04-30 | 2014-02-05 | 損傷組織の機能的再生促進医薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110097309A1 (enExample) |
| EP (1) | EP2301560A4 (enExample) |
| JP (3) | JP5814549B2 (enExample) |
| KR (1) | KR20110027665A (enExample) |
| CN (1) | CN102076351A (enExample) |
| AU (1) | AU2009240885A1 (enExample) |
| BR (1) | BRPI0911436A2 (enExample) |
| CA (1) | CA2722906A1 (enExample) |
| RU (1) | RU2010148785A (enExample) |
| WO (1) | WO2009133940A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009133943A1 (ja) | 2008-04-30 | 2009-11-05 | 株式会社ジェノミックス | 生体内機能的細胞の高効率採取法 |
| CN102076351A (zh) * | 2008-04-30 | 2011-05-25 | 吉诺米克斯股份有限公司 | 损伤组织的功能性再生促进药物 |
| JP5660889B2 (ja) * | 2008-04-30 | 2015-01-28 | 株式会社ジェノミックス | 末梢循環への骨髄由来多能性幹細胞動員薬 |
| KR20120135190A (ko) | 2009-10-28 | 2012-12-12 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | 골수 간엽계 및/또는 다능성 줄기세포의 혈중 동원(動員)에 의한 조직 재생 촉진제 |
| JP5852773B2 (ja) * | 2010-06-01 | 2016-02-03 | ピアス株式会社 | 骨髄間葉系幹細胞の誘引剤の製造方法、骨髄間葉系幹細胞の誘引方法、及び、骨髄間葉系幹細胞の誘引剤を製造するための使用 |
| EP3358011B1 (en) | 2011-04-26 | 2020-03-04 | StemRIM Inc. | Peptide for inducing regeneration of tissue and use thereof |
| JP6253589B2 (ja) | 2012-10-25 | 2017-12-27 | 株式会社ジェノミックス | Ｈｍｇｂ１断片を利用した新規心筋梗塞の治療法 |
| DK2913059T3 (en) | 2012-10-25 | 2018-06-25 | Genomix Co Ltd | Hitherto UNKNOWN PROCEDURE FOR TREATMENT OF SPINE INJURY USING HMGB1 FRAGMENT |
| CN108367068B (zh) * | 2015-09-14 | 2021-08-03 | 拉瓦尔大学 | 用于治疗白血病的抗-s100a8 |
| AU2018213671B2 (en) | 2017-01-27 | 2024-06-06 | Osaka University | Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure |
| MX2019012738A (es) | 2017-04-25 | 2020-02-07 | Shionogi & Co | Peptido para inducir la regeneracion de tejido, y uso del mismo. |
| WO2019017355A1 (ja) * | 2017-07-18 | 2019-01-24 | 株式会社資生堂 | 間葉系幹細胞誘引剤 |
| AU2018376452A1 (en) | 2017-12-01 | 2020-06-25 | Osaka University | Ectodermal mesenchymal stem cells and method for producing same |
| EP3718561A4 (en) | 2017-12-01 | 2021-07-21 | Stemrim Inc. | Therapy for inflammatory bowel disease |
| US20210024594A1 (en) | 2018-02-08 | 2021-01-28 | StemRIM Inc. | Therapeutic Agent for Psoriasis |
| US12304933B2 (en) | 2018-10-05 | 2025-05-20 | StemRIM Inc. | Disease treatment drug based on mesenchymal-stem-cell mobilization |
| EP3756679A1 (en) * | 2019-06-28 | 2020-12-30 | Université de Genève | Compositions for use in the treatment of insulin deficiency conditions |
| CN111494423B (zh) * | 2020-04-22 | 2022-01-25 | 上海市东方医院（同济大学附属东方医院） | 一种干细胞组合物及其应用和干细胞滴液 |
| CN115058388A (zh) * | 2022-03-14 | 2022-09-16 | 福建医科大学附属协和医院 | 间充质干细胞创面修复优势功能亚群及其鉴定和应用 |
| CN120837666B (zh) * | 2025-09-22 | 2026-02-10 | 中国人民解放军军事科学院军事医学研究院 | 靶向巨噬细胞s100a9蛋白在肝纤维化治疗中的应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5658894A (en) * | 1989-04-23 | 1997-08-19 | The Trustees Of The University Of Pennsylvania | Compositions for inhibiting restenosis |
| JP3018313B2 (ja) * | 1996-02-23 | 2000-03-13 | 雪印乳業株式会社 | 骨形成促進及び骨吸収防止剤 |
| EP1114862A3 (de) * | 1999-11-17 | 2003-08-06 | Switch Biotech Aktiengesellschaft | Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen |
| HK1052372A1 (zh) * | 2000-02-24 | 2003-09-11 | Xcyte Therapies, Inc. | 细胞的同步刺激和富集 |
| US20040191246A1 (en) * | 2003-02-26 | 2004-09-30 | Connelly Patrick R. | Process for in vivo treatment of specific biological targets in bodily fluid |
| EP1390058A2 (en) * | 2001-04-30 | 2004-02-25 | Switch Biotech Aktiengesellschaft | Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances |
| DE10121254A1 (de) * | 2001-04-30 | 2002-11-07 | Switch Biotech Ag | MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind |
| JP2005520483A (ja) * | 2001-05-09 | 2005-07-14 | ユニバーシティ ホスピタルズ オブ クリーブランド | 新規遺伝子マーカーを用いる皮膚に対する紫外線損傷の評価、それに関連する方法及び組成物 |
| US7220723B2 (en) * | 2001-05-15 | 2007-05-22 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| ITMI20011986A1 (it) * | 2001-09-25 | 2003-03-25 | San Raffaele Centro Fond | Metodo e composizione per l'attivazione di cellule presentanti l'antigene |
| KR100704158B1 (ko) * | 2001-11-19 | 2007-04-05 | 교와 핫꼬 고교 가부시끼가이샤 | 다분화능 줄기세포를 조직으로부터 말초혈로 동원하는약제 |
| DE60326453D1 (de) * | 2002-07-03 | 2009-04-16 | Ct Cardiologico Monzino S P A | Die verwendung von hmgb1 zur behandlung von gewebeverletzungen und/oder zur unterstützung der gewebewiederherstellung |
| US7553488B2 (en) * | 2002-07-05 | 2009-06-30 | UNIVERSITé LAVAL | Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions |
| GB0226251D0 (en) * | 2002-11-11 | 2002-12-18 | San Raffaele Centro Fond | Acetylated protein |
| EP1579221A2 (de) * | 2003-01-03 | 2005-09-28 | Alcedo Biotech GmbH | Verwendungen von hmgb, hmgn, hmga proteinen |
| WO2004084928A1 (en) * | 2003-03-28 | 2004-10-07 | UNIVERSITé LAVAL | S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment |
| US20090062187A1 (en) * | 2004-07-20 | 2009-03-05 | Marco Bianchi | Use of Hmgb1 for Wound Healing |
| KR100593397B1 (ko) * | 2004-10-27 | 2006-06-28 | 한국원자력연구소 | 중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제 |
| WO2006047820A1 (en) * | 2004-11-01 | 2006-05-11 | Newsouth Innovations Pty Limited | Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation |
| CA2636788A1 (en) * | 2006-10-30 | 2008-05-08 | Genomix Co., Ltd. | Hmgb protein for use in promoting tissue regeneration |
| WO2009133943A1 (ja) * | 2008-04-30 | 2009-11-05 | 株式会社ジェノミックス | 生体内機能的細胞の高効率採取法 |
| JP5660889B2 (ja) * | 2008-04-30 | 2015-01-28 | 株式会社ジェノミックス | 末梢循環への骨髄由来多能性幹細胞動員薬 |
| CN102076351A (zh) * | 2008-04-30 | 2011-05-25 | 吉诺米克斯股份有限公司 | 损伤组织的功能性再生促进药物 |
-
2009
- 2009-04-30 CN CN2009801252435A patent/CN102076351A/zh active Pending
- 2009-04-30 JP JP2010510169A patent/JP5814549B2/ja not_active Expired - Fee Related
- 2009-04-30 BR BRPI0911436A patent/BRPI0911436A2/pt not_active Application Discontinuation
- 2009-04-30 EP EP09738877A patent/EP2301560A4/en not_active Withdrawn
- 2009-04-30 KR KR1020107026780A patent/KR20110027665A/ko not_active Withdrawn
- 2009-04-30 RU RU2010148785/10A patent/RU2010148785A/ru not_active Application Discontinuation
- 2009-04-30 US US12/990,060 patent/US20110097309A1/en not_active Abandoned
- 2009-04-30 AU AU2009240885A patent/AU2009240885A1/en not_active Abandoned
- 2009-04-30 WO PCT/JP2009/058519 patent/WO2009133940A1/ja not_active Ceased
- 2009-04-30 CA CA2722906A patent/CA2722906A1/en not_active Abandoned
-
2014
- 2014-02-05 JP JP2014019961A patent/JP5960735B2/ja active Active
-
2016
- 2016-01-18 JP JP2016006778A patent/JP2016104790A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022003116A (es) | Factor ix modificado, y composiciones, metodos y usos para la transferencia de genes a celulas, organos y tejidos. | |
| WO2018191502A3 (en) | Anti-cd137 antibodies and methods of use thereof | |
| EP4289484A3 (en) | Anti-ctla-4 antibodies and methods of use thereof | |
| MX2021006615A (es) | Proteinas de union triespecificas y metodos de uso. | |
| EA201992609A1 (ru) | Слитые белки, содержащие интерлейкин-2, и их применения | |
| NZ749355A (en) | Anti-tim-3 antibodies and methods of use thereof | |
| JP2016514956A5 (enExample) | ||
| BR112016029318A2 (pt) | tratamento de mielomas | |
| EA201692361A1 (ru) | Лентивирусные векторы | |
| MY189425A (en) | Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use | |
| WO2015197598A3 (en) | Multispecific antigen binding proteins | |
| EA201891317A2 (ru) | Терапевтические мишени для коррекции гена дистрофина человека с помощью редактирования генов и способы их применения | |
| WO2016207273A3 (en) | Multispecific antigen binding proteins | |
| MY181199A (en) | Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use | |
| CY1115502T1 (el) | Παραγοντες διεγερσης αποπτωσης για τη θεραπεια καρκινου και ανοσων και αυτοανοσων ασθενειων | |
| SG10201809075XA (en) | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues | |
| MX2019013587A (es) | Proteinas agonistas del receptor del ligando que induce la apoptosis relacionada con el factor de necrosis de tumor de cadena individual. | |
| CY1125513T1 (el) | Προερχομενα απο λιπωδη ιστο στρωματικα αρχεγονα κυτταρα για χρηση σε αγωγη δυσαγωγων περιπλοκων περιπρωκτικων συριγγιων σε νοσο toy crohn | |
| MX2018015629A (es) | Sistema de vector viral adeno-asociado traslapado doble para la expresion de abc4a. | |
| WO2016164669A3 (en) | Antibody therapeutics that bind cd38 | |
| RU2016108808A (ru) | Терапевтическое применение vegf-c и ccbe1 | |
| MX2019008105A (es) | Virus. | |
| SG10201805646WA (en) | Angiopoietin-like 4 antibodies and methods of use | |
| WO2016020882A3 (en) | Angiopoetin-like 4 (angptl4) antibodies and methods of use | |
| IL270985A (en) | Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome |